| 摘要 |
<p>The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I or formula II; and methods for treating or preventing autoimmune diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of rheumatoid arthritis, Crohn's disease, multiple sclerosis, systemic lupus erythematosus, dermatitis, ulcerative colitis, inflammatory bowel disease and other immune system related diseases.</p> |
